DE60308836D1 - Ophthalmische zubereitung mit ascomycin - Google Patents

Ophthalmische zubereitung mit ascomycin

Info

Publication number
DE60308836D1
DE60308836D1 DE60308836T DE60308836T DE60308836D1 DE 60308836 D1 DE60308836 D1 DE 60308836D1 DE 60308836 T DE60308836 T DE 60308836T DE 60308836 T DE60308836 T DE 60308836T DE 60308836 D1 DE60308836 D1 DE 60308836D1
Authority
DE
Germany
Prior art keywords
ascomycin
ophthalmic preparation
ophthalmic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60308836T
Other languages
English (en)
Other versions
DE60308836T2 (de
Inventor
Saunier Maggy Babiole
Jean-Claude Bizec
Pik-Han Wong
Shau-Fong Yen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27791682&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60308836(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60308836D1 publication Critical patent/DE60308836D1/de
Publication of DE60308836T2 publication Critical patent/DE60308836T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60308836T 2002-03-04 2003-03-03 Ophthalmische zubereitung mit ascomycin Expired - Lifetime DE60308836T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US36151502P 2002-03-04 2002-03-04
US361515P 2002-03-04
US40927502P 2002-09-09 2002-09-09
US409275P 2002-09-09
PCT/EP2003/002156 WO2003074054A1 (en) 2002-03-04 2003-03-03 Ophthalmic composition comprising ascomycin

Publications (2)

Publication Number Publication Date
DE60308836D1 true DE60308836D1 (de) 2006-11-16
DE60308836T2 DE60308836T2 (de) 2007-04-26

Family

ID=27791682

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60308836T Expired - Lifetime DE60308836T2 (de) 2002-03-04 2003-03-03 Ophthalmische zubereitung mit ascomycin

Country Status (28)

Country Link
US (4) US20050220823A1 (de)
EP (1) EP1482936B1 (de)
JP (1) JP4740542B2 (de)
KR (1) KR100992948B1 (de)
CN (1) CN1297270C (de)
AR (1) AR038628A1 (de)
AT (1) ATE341326T1 (de)
AU (1) AU2003218679B2 (de)
BR (1) BR0308184A (de)
CA (1) CA2477769C (de)
CO (1) CO5611133A2 (de)
DE (1) DE60308836T2 (de)
DK (1) DK1482936T3 (de)
EC (1) ECSP045277A (de)
EG (1) EG24403A (de)
ES (1) ES2274214T3 (de)
HK (1) HK1071301A1 (de)
IL (2) IL163657A0 (de)
MX (1) MXPA04008571A (de)
MY (1) MY137563A (de)
NO (1) NO20044092L (de)
NZ (1) NZ534690A (de)
PE (1) PE20030828A1 (de)
PL (1) PL210870B1 (de)
PT (1) PT1482936E (de)
RU (1) RU2322982C2 (de)
TW (1) TW200305437A (de)
WO (1) WO2003074054A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100355455C (zh) 2002-07-15 2007-12-19 爱尔康公司 用于眼内使用的非聚合亲脂性药物植入组合物
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
GB0307866D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
BRPI0705564B8 (pt) * 2007-10-10 2021-05-25 Embrapa Pesquisa Agropecuaria sistema do tipo cristal líquido contínuo contendo co-solvente portador de substâncias fracamente solúveis em água, seu processo de obtenção e seus usos
EP2238878A1 (de) 2009-04-09 2010-10-13 Nestec S.A. Getränkezubereitungsvorrichtung mit einem Verschlussmechanismus mit Mitteln zur starken Abnahme der Kraft
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
US8728497B2 (en) * 2009-05-12 2014-05-20 Galenica Ab Oil-in-water emulsion of mometasone and propylene glycol
WO2011079127A1 (en) * 2009-12-22 2011-06-30 Abbott Laboratories Abt-263 capsule
EP2555748A2 (de) * 2010-04-07 2013-02-13 Allergan, Inc. Konservierungsstoffkombinationen für ophthalmische zusammensetzungen
RU2531937C2 (ru) * 2012-05-14 2014-10-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазной мази
EP2664329A1 (de) * 2012-05-15 2013-11-20 F. Holzer GmbH Ophthalmologisches Vehikelsystem
WO2014153733A1 (en) * 2013-03-27 2014-10-02 Comprehensive Drug Enterprises, Ltd. Ophthalmic composition, method for preparing the same, and use of the same
CN105792848B (zh) * 2013-11-29 2021-04-09 乐敦制药株式会社 眼科用或耳鼻科用水性组合物
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US10606760B2 (en) * 2017-08-23 2020-03-31 Samsung Electronics Co., Ltd. Nonvolatile memory devices and methods of controlling the same
EP3741367A1 (de) 2019-05-21 2020-11-25 Premark Pharma GmbH Behandlung von augenerkrankungen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2066915T3 (es) * 1989-07-05 1995-03-16 Fujisawa Pharmaceutical Co Composicion liquida acuosa para uso externo.
ES2099112T3 (es) * 1990-09-04 1997-05-16 Fujisawa Pharmaceutical Co Pomadas que contienen un compuesto triciclico.
PH31204A (en) * 1990-11-02 1998-05-05 Fujisawa Pharmaceutical Co Pharmaceutical composition.
CA2054983A1 (en) * 1990-11-08 1992-05-09 Sotoo Asakura Suspendible composition and process for preparing the same
AU680813B2 (en) * 1992-08-28 1997-08-14 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
JPH06345646A (ja) * 1993-06-08 1994-12-20 Fujisawa Pharmaceut Co Ltd ローション剤
EP0664705B1 (de) * 1993-08-18 2000-10-04 Alcon Laboratories, Inc. Zusammensetzungen von ergolinderivaten zur behandlung des glaukoms
CA2201134A1 (en) * 1994-10-10 1996-04-18 Alfred Sallmann Ophthalmic and aural compositions containing diclofenac potassium
MX9702699A (es) * 1994-10-26 1997-06-28 Novartis Ag Composiciones farmaceuticas.
FR2732598B1 (fr) * 1995-04-10 1997-05-09 Oreal Utilisation de sel de metaux alcalino-terreux pour le traitement des prurits et des dysesthesies oculaires ou palpebraux
FR2755852B1 (fr) * 1996-11-15 1998-12-24 Oreal Utilisation d'un alkylether de glycerol dans une composition cosmetique et/ou dermatologique comme actif pour le traitement de la seborrhee et de l'acne
DE69936195T2 (de) * 1998-04-27 2007-09-13 Astellas Pharma Inc. Pharmazeutische gelformulierung enthaltend eine trizyklische substanz (fk-506/tacrolimus)
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
MXPA01010988A (es) * 1999-04-30 2004-04-21 Sucampo Ag Uso de un compuesto macrolido para el tratamiento del ojo seco.

Also Published As

Publication number Publication date
DK1482936T3 (da) 2007-01-08
US20110152307A1 (en) 2011-06-23
PL370917A1 (en) 2005-06-13
JP2005529851A (ja) 2005-10-06
PL210870B1 (pl) 2012-03-30
US20100113501A1 (en) 2010-05-06
EG24403A (en) 2009-04-29
US20050220823A1 (en) 2005-10-06
PT1482936E (pt) 2007-01-31
DE60308836T2 (de) 2007-04-26
KR100992948B1 (ko) 2010-11-08
AU2003218679B2 (en) 2007-04-05
WO2003074054A1 (en) 2003-09-12
AU2003218679A1 (en) 2003-09-16
EP1482936A1 (de) 2004-12-08
EP1482936B1 (de) 2006-10-04
IL163657A (en) 2009-11-18
RU2004129593A (ru) 2005-09-10
BR0308184A (pt) 2005-01-11
MXPA04008571A (es) 2004-12-06
US20120015971A1 (en) 2012-01-19
CN1638769A (zh) 2005-07-13
NO20044092L (no) 2004-09-27
PE20030828A1 (es) 2003-11-04
RU2322982C2 (ru) 2008-04-27
CN1297270C (zh) 2007-01-31
AR038628A1 (es) 2005-01-19
ECSP045277A (es) 2004-10-26
KR20040094718A (ko) 2004-11-10
CA2477769A1 (en) 2003-09-12
IL163657A0 (en) 2005-12-18
HK1071301A1 (en) 2005-07-15
CO5611133A2 (es) 2006-02-28
ES2274214T3 (es) 2007-05-16
CA2477769C (en) 2011-01-18
ATE341326T1 (de) 2006-10-15
NZ534690A (en) 2007-06-29
TW200305437A (en) 2003-11-01
MY137563A (en) 2009-02-27
JP4740542B2 (ja) 2011-08-03

Similar Documents

Publication Publication Date Title
DE60327864D1 (de) Ballondissektor mit kanüle
DE50311697D1 (de) Zwischenwirbelimplantat mit kalottenartigen gelenkflächen
DE602004020183D1 (de) Schrittmacher mit av-intervall-optimierung
DE60319848D1 (de) Medikament mit mesenchym-stammzellen
DE602004002987D1 (de) Linseneinführsystem
IS8043A (is) Gervigras
DE60311076D1 (de) Nanostrukturen mit pilin-protein
DE50311234D1 (de) Zwischenwirbelimplantat mit temporären blockiermitteln
DE60308332D1 (de) Chinazolinverbindungen mit therapeutischem nutzen
HK1071301A1 (en) Ophthalmic composition comprising ascomycin
ATE472576T1 (de) Polyalkenamine mit verbesserten anwendungseigenschaften
DE602004006816D1 (de) Ladegerät
DE60234840D1 (de) Ascomycin enthaltende ophthalmische zubereitungen
DE50308359D1 (de) Armlehne
DE50308343D1 (de) Armlehne
DE602004014252D1 (de) Avermectinmonosaccharidderivate mit pestiziden eigenschaften
SE0300137L (sv) Infusionssats
DE60322421D1 (de) Verbesserter brillenbügel
DE60328921D1 (de) Kondom mit integriertem wulstaufbau
DE602004032351D1 (de) Kulierstrick- oder kulierwirkmaschine mit bewegbarer platine
DE60311138D1 (de) Pll mit symmetrischem quadrikorrelator
DE602004024223D1 (de) Drehscheibe mit positionseinstellung
DE50309332D1 (de) Empfangsanordnung mit vorverstärkerschaltung
DE60335297D1 (de) Cloque mit internen verbindungselementen
TW592318U (en) Improved sunglasses structure with rotatable lens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN